Users Online: 859 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 

Year : 2014  |  Volume : 30  |  Issue : 3  |  Page : 383-386

A prospective controlled study to assess the antiemetic effect of midazolam following intragastric balloon insertion

Medical Research Institute-Alexandria University, Alexandria Governorate, Egypt

Correspondence Address:
Sherif A Abdelhamid
Lecturer of Anaesthesia and Surgical Intensive Care-Medical Research Institute-Alexandria University, Alexandria Governorate
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-9185.137272

Rights and Permissions

Background and Aims: Obesity is a chronic disease with considerable morbidity and mortality. The intragastric balloon appears attractive for a group of patients who do not respond to medical therapy and who are not surgical candidates. Postoperative nausea and vomiting (PONV) are distressing adverse effects for these patients. Midazolam has been used as an antiemetic, both as a preventive or rescue medication.The study aims at studying effect of combined use of ondansetron and midazolam to decrease the PONV following intragastric balloon insertion. Materials and Methods: The study was conducted on 54 patients presented for intragastric balloon insertion during the period between 1 st of January 2012 and 31 December 2012. Patients were randomly allocated into two groups; Ondansetron group and ondansetron/midazolam group. Patients were assessed for the incidence of nausea and vomiting, nausea and vomiting score, degree of sedation and occurrence of adverse effects during the first 24 h after the operation. Results: Incidence of nausea and/or vomiting during the first 24 h postoperatively was 66% in the ondansetron group, while 34.5% among the ondansetron-midazolam group. There was significant reduction of nausea and/or vomiting in the second group. Degree of postoperative sedation was also significantly different between the two groups in the immediate postoperative period and 30min postoperatively. Conclusion: Use of midazolam combined with ondansetron provides significant reduction and therefore better outcome regarding nausea and vomiting following intragastric balloon insertion.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded357    
    Comments [Add]    
    Cited by others 7    

Recommend this journal